Online training could sharpen Pathologists' eye for melanoma
NCT ID NCT05004792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an online training platform called DermLoop Learn can improve how pathologists diagnose melanoma from skin lesion images. 258 pathologists will be randomly assigned to receive the training or not, and their diagnostic accuracy will be compared against a panel of expert pathologists. The goal is to see if additional dermoscopy training helps pathologists make more accurate diagnoses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DermLoop Learn digital educational platform
What this could lead to
If successful, this could show that online dermoscopy training improves pathologists' accuracy in diagnosing melanoma, potentially leading to better patient outcomes.
What could go wrong
This is an early-stage study that measures diagnostic accuracy, not patient health outcomes. The training may not translate to real-world improvements, and results depend on pathologists' engagement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••